Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

ACS News

Pat Confalone honored as Distinguished Eagle Scout

by Neil Lupton, ACS member
July 22, 2024 | A version of this story appeared in Volume 102, Issue 22

 

Pat Confalone posing with an award that says "Boy Scouts of America" and has his name on it in his hand.
Credit: Courtesy of Pat Confalone
Pat Confalone

Pat Confalone, former chairman of the American Chemical Society Board of Directors, has been named a Distinguished Eagle Scout by the Boy Scouts of America. Confalone is a distinguished scientist with a career that includes groundbreaking research and leadership in the fields of bioorganic chemistry and pharmaceuticals.

The designation is awarded to Eagle Scouts who have distinguished themselves at the national or international level. Of 2,500,000-plus scouts who have earned the Eagle Scout Award, fewer than 2,000 have been honored as Distinguished Eagle Scouts.

Pat’s principal contributions were made as part of DuPont, where he developed medications to treat hypertension and AIDS. As vice president of global R&D for DuPont Health, Nutrition, and Crop Protection, he oversaw a team of 300 scientists and developed a robust roster of novel products with worldwide sales exceeding $1 billion annually.

Confalone graduated from the Massachusetts Institute of Technology and earned a PhD from Harvard University. He holds more than 50 US patents. He has received the Harvard Graduate Society Prize, the Alpha Chi Sigma Award, and the ACS Earl B. Barnes Award for Leadership in Chemical Research Management.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.